Related Experiment Video
Updated: Dec 13, 2025
11:22
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
17.8K
Stem Cell Therapy as a Treatment for Osteogenesis Imperfecta
Cecilia Götherström1, Lilian Walther-Jallow2
1Department of Clinical Science, Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institutet, ANA Futura, floor 8, Alfred Nobels Allé 8, 141 52 Huddinge, Stockholm, Sweden. Cecilia.Gotherstrom@ki.se.
Current Osteoporosis Reports
|July 26, 2020
Summary
Mesenchymal stem cells (MSC) show promise for treating Osteogenesis Imperfecta (OI). These cells are safe, easy to manufacture, and can potentially regenerate bone tissue, offering new hope for OI patients.
Area of Science:
- Regenerative Medicine
- Cell-based Therapies
- Skeletal Dysplasias
Background:
- Osteogenesis Imperfecta (OI) is a debilitating genetic disorder characterized by brittle bones and limited treatment options.
- Mesenchymal Stem Cells (MSCs) are multipotent stromal cells with immunomodulatory and regenerative properties.
Purpose of the Study:
- To review the therapeutic potential of Mesenchymal Stem Cells (MSCs) for treating Osteogenesis Imperfecta (OI).
- To explore the safety, efficacy, and mechanisms of MSC-based therapies in OI.
Main Methods:
- Review of preclinical studies and initial clinical trials involving MSC transplantation for OI.
- Analysis of MSC characteristics, including differentiation potential, immunogenicity, and migratory capacity.
Main Results:
- MSCs possess a favorable safety profile, low immunogenicity, and ease of manufacturing.
- MSC transplantation, particularly with fetal MSCs, demonstrates potential for bone regeneration in OI via osteogenic differentiation and paracrine signaling.
- Intravenous administration of MSCs has shown promising clinical effects in early-stage OI treatment.
Conclusions:
- Mesenchymal Stem Cells (MSCs) represent a promising therapeutic candidate for Osteogenesis Imperfecta (OI) due to their regenerative capabilities and safety.
- Further clinical investigation is warranted to fully establish MSCs as a standard treatment for OI.
- Fetal-derived MSCs may offer superior therapeutic potential compared to adult-derived MSCs for OI treatment.
Keywords:
Brittle bonesMesenchymal stem cellsOsteogenesis imperfectaPrenatal therapyStem cell therapyStem cell transplantationMore Related Videos
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
01:17Stem Cell Culture
5.9K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.9K
01:22iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
01:22Bone Marrow Sampling and Transplants
713
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
713